Lynx Dx was founded by Arul Chinnaiyan in 2015.

Who are Lynx Dx's investors?

Lynx Dx's investors include ID Ventures.

How much funding has Lynx Dx raised?

Lynx Dx has disclosed $925K raised across 1 round.

Where is Lynx Dx headquartered?

Lynx Dx is headquartered in Northville, US.

Lynx Dx

Northville, US · Founded 2015 · Michigan corporation · 1 known investors

Find your way into Lynx Dx

Paths you didn't know you had: your email and LinkedIn already hold routes to the Lynx Dx team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Lynx Dx develops MyProstateScore 2.0 (MPS2), a urine test that analyzes 18 gene transcripts to predict the presence of clinically significant prostate cancer. The diagnostic can be run as a biomarker-only test or combined with clinical risk factors, generating individualized patient reports for healthcare providers.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Lynx Dx was founded in 2015 by Arul Chinnaiyan.

Arul ChinnaiyanFounder, Director

Matt MartinCFO

Yashar NikafsCEO

Investors · 1

ID Ventureslisted by ID VenturesDetroit · $50K – $250K

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$925K disclosed across 1 round · 2020

▶$925KraisedJan 2020 · 10 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Matt MartinExecutive Officer
Arul ChinnaiyanExecutive Officer, Director
Yashar NikafsExecutive Officer

Offering amount: $2M
Amount sold: $925K
Minimum investment: $25K
First sale: Jan 2020
Incorporated: Corporation, Michigan, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

Prostate Cancer FoundationThe Prostate Cancer Foundation is a philanthropic organization that funds life-saving prostate cancer research through grants to leading cancer centers worldwide. It advances treatment options and patient outcomes through scientific research investments.

American Cancer Society (ACS)The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.

CancerresearchukCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.

MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.

Companies working in the same space as Lynx Dx.

Frequently asked questions

What does Lynx Dx do?: Lynx Dx develops MyProstateScore 2.0 (MPS2), a urine test that analyzes 18 gene transcripts to predict the presence of clinically significant prostate cancer. The diagnostic can be run as a biomarker-only test or combined with clinical risk factors, generating individualized patient reports for healthcare providers.
Who founded Lynx Dx?: Lynx Dx was founded by Arul Chinnaiyan in 2015.
Who are Lynx Dx's investors?: Lynx Dx's investors include ID Ventures.
How much funding has Lynx Dx raised?: Lynx Dx has disclosed $925K raised across 1 round.
Where is Lynx Dx headquartered?: Lynx Dx is headquartered in Northville, US.